Table 3 Preferences regarding consent procedure for research use of residual tissue
From: A trial of consent procedures for future research with clinically derived biological samples
All respondents ( n =239) | |
|---|---|
Type of consent procedure | |
‘One-time consent’ is the appropriate consent procedure | 81 (34%) |
‘Opt-out plus’ is the appropriate consent procedure | 103 (43%) |
‘Opt-out’ is the appropriate consent procedure | 37 (16%) |
No information needs to be provided | 18 (8%) |
When should information be provided? | |
I think it should be given before or at intake | 93 (39%) |
I think it should be provided during the hospital stay | 50 (21%) |
I think it should be provided after the hospital stay | 69 (29%) |
I think it should be offered otherwise | 28 (11%) |
How should written information be provided? | |
In a general hospital leaflet | 100 (42%) |
In a specific leaflet about residual tissue and research | 119 (50%) |
I think no information should be provided | 12 (5%) |
Information should be provided otherwise | 6 (3%) |
